Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study

We aimed to identify prognostic factors associated with progression-free survival (PFS) and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients treated with sorafenib. We investigated 177 patients, including 116 who received sorafenib as first-line therapy, using the Cox regress...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Kim, Sohee, Nam, Byung-Ho, Lee, Sang Eun, Kim, Choung-Soo, Seo, Ill Young, Kim, Tae Nam, Hong, Sung-Hoo, Kwon, Tae Gyun, Seo, Seong Il, Joo, Kwan Joong, Song, Kanghyon, Kwak, Cheol, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320076/
https://www.ncbi.nlm.nih.gov/pubmed/28271073
http://dx.doi.org/10.1155/2017/9215930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320076/
https://www.ncbi.nlm.nih.gov/pubmed/28271073
http://dx.doi.org/10.1155/2017/9215930

Ejemplares similares